Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Microbiol. 2009 Feb;12(1):61-6. doi: 10.1016/j.mib.2008.12.007. Epub 2009 Jan 23.

Role of Pseudomonas aeruginosa type III effectors in disease.

Author information

  • 1Departments of Microbiology/Immunology and Medicine, Microbial Pathogenesis and Host Defense Program, Box 0654 UCSF, 513 Parnassus Ave, San Francisco, CA 94143, USA. jengel@medicine.ucsf.edu

Abstract

Pseudomonas aeruginosa uses a type III secretion system (T3SS) to directly inject four known effectors into host cells. ExoU is a potent cytotoxin with phospholipase A2 activity that causes rapid necrotic death in many cell types. The biological function of ExoY, an adenylate cyclase, remains incompletely defined. ExoS and ExoT are closely related bifunctional proteins with N-terminal GTPase activating protein (GAP) activity toward Rho family proteins and C-terminal ADP ribosylase (ADPRT) activity toward distinct and non-overlapping set of targets. While almost no strain encodes or secretes all four effectors, the commonly found combinations of ExoU/ExoT or ExoS/ExoT provides redundant and failsafe mechanisms to cause mucosal barrier injury, inhibit many arms of the innate immune response, and prevent wound repair.

PMID:
19168385
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk